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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

MAKING THE WADA PROHIBITED LIST: SHOW ME THE DATA

SRIKUMARAN MELETHIL*
“Esteem Literacy and Despise Martiality”1
“So let the Games begin! I plan to adopt the English poet Samuel Taylor
Coleridge’s advice and follow the events having willfully suspended disbelief,
confident that the playing field is level, that no one is on drugs and that no
athlete has a concealed bionic assist.”2

I. INTRODUCTION
Illegal drug use in sports has been a matter of much recent concern among
lawmakers and organizations responsible for regulating sports, such as the
International Olympics Committee (IOC), the National Football League, and
Major League Baseball. The two widely stated reasons for such concerns are
health risk to athletes and the unfair advantage gained (the so-called
“performance enhancement”) by such drug use.3 The widely publicized United
States Senate hearing on March 17, 2005, regarding steroid use in professional
baseball is one such example.4 Sensational, tragic, and/or misleading issues, in
addition to the lack of reliable information, obfuscate the truth about the extent
of drug use in sports and the associated health risks.5
This Review provides a scientific analysis of the efforts made by one
major international organization, namely the IOC, to address these two issues
* Ph.D., J.D., Professor Emeritus, Schools of Pharmacy and Medicine, University of MissouriKansas City, Attorney at Law, Lenexa, KS, email: melethils@umkc.edu.
1. Ancient Chinese Proverb
2. Donald Kennedy, Editorial: Here Come the Olympics, 305 SCIENCE 573, 573 (2004)
(note to readers from Editor in Chief).
3. See Restoring Faith in America’s Pastime: Evaluating Major League Baseball’s Efforts
to Eradicate Steroid Use: Hearing Before the H. Comm. on Gov’t Reform, 109th Cong. 8 (2005),
available at http://frwebgate.access.gpo.gov/cgi-bin/useftp.cgi?IPaddress=162.140.64.21&file
name=20323.pdf&directory=/diskb/wais/data/109_house_hearings [hereinafter Restoring Faith in
America’s Pastime] (statement of Chairman Tom Davis).
4. See id.
5. See Duff Wilson, After Young Athlete’s Suicide, Steroids Are Called the Culprit, N.Y.
TIMES, Mar. 10, 2005, at A1 (reporting teenager’s suicide resulting from an abrupt withdrawal of
steroid use and the failure of the treating physician to recognize the consequences of such abrupt
withdrawal).
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of health risk to and unfair advantage for athletes who use drugs in competition
to enhance their chances of winning. Suggestions for improvement of the
currently used drug testing procedures are also presented. Part II provides a
critical review of the inclusion criteria used by the World Anti-Doping Agency
(WADA) to list a substance or a method in its Prohibited List.6 WADA is the
arm of the IOC responsible for prevention of drug abuse. Part III, using
selected examples, focuses on the need for the IOC to make more sciencebased decisions relating to the addition or deletion of a given substance or
method to the Prohibited List; such decisions can also enhance athlete safety,
as in the case of erythropoietin. Specific suggestions for improving the drug
testing programs are presented in Part IV.
II. THE PROHIBITED LIST: CRITERIA FOR INCLUSION
The Prohibited List is an exhaustive and extensive list of prohibited
substances and methods provided by WADA.7 Prohibited substances are
classified in five groups: anabolic agents, hormones, beta-2 agonists, antiestrogenic agents, and diuretics.8 Prohibited methods include oxygen transfer
enhancements, various methods used to tamper with samples, and gene
doping.9
WADA does not publicly disclose the scientific reasons or the literature
(bibliography) used to include them in this list. In general, there is a paucity of
competent data to support the conclusion that the majority of the listed
substances in fact enhance performance, which is the main reason athletes use
various drugs, methods, or dietary supplements.
WADA states that anti-doping programs are necessary to preserve “the
spirit of sport,” which consists of: “[e]thics, fair play and honesty[;] [h]ealth[;]
[e]xcellence in performance[;] [c]haracter and education[;] [f]un and joy[;]
[t]eamwork[;] [d]edication and commitment[;] [r]espect for rules and laws[;]
[r]espect for self and other participants[;] [c]ourage[;] [and] [c]ommunity and
solidarity.”10 Doping is defined as using or attempting to use prohibited
substances, having prohibited substances or its metabolites or markers in one’s
bodily fluids, refusing to provide a sample for testing without “compelling
justification,” refusing information about one’s whereabouts or missed tests,
tampering or attempting to tamper with one’s samples, possessing or
6. To view the substances and methods listed on the current Prohibited List, see WORLD
ANTI-DOPING AGENCY, WORLD ANTI-DOPING CODE: THE 2005 PROHIBITED LIST:
INTERNATIONAL STANDARD (2005), available at http://www.wada-ama.org/rtecontent/document/
list_2005.pdf [hereinafter PROHIBITED LIST].
7. WORLD ANTI-DOPING AGENCY, WORLD ANTI-DOPING CODE, § 4.2 cmt. (2003),
http://www.wada-ama.org/rtecontent/document/code_v3.pdf [hereinafter WADA CODE].
8. PROHIBITED LIST, supra note 6, §§ S1–S5.
9. Id. §§ M1–M3.
10. WADA CODE, supra note 7, at 3 (introduction).
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trafficking any of the prohibited substances and/or methods, and/or
administering or encouraging the use of prohibited substances to other
athletes.11
The three major criteria for banning the use of a given substance or method
are:
Medical or other scientific evidence, pharmacological effect or experience that
the substance or method has the potential to enhance or enhances sports
performance;
Medical or other scientific evidence, pharmacological effect, or experience that
the Use of the substance or method represents an actual or potential risk to the
Athlete;
WADA’s determination that the Use of the substance or method violates the
spirit of sport . . . .12

In addition, a “substance or method shall also be included on the Prohibited
List if WADA determines there is medical or other scientific evidence,
pharmacological effect or experience that the substance or method has the
potential to mask the Use of other Prohibited Substances and Prohibited
Methods.”13
A substance or method that meets two of the three criteria listed above
“shall be considered for inclusion on the Prohibited List . . . .”14 The Code
further states that all inclusion decisions “shall be final and shall not be subject
to challenge by an Athlete or other Person based on an argument that the
substance or method was not a masking agent or did not have the potential to
enhance performance, represent a health risk, or violate the spirit of sport.”15
An argument does not necessarily include evidence in support of an
argument.16 The inability to challenge a scientific assertion by WADA with
respect to performance enhancement or health risk undermines its claim that
the Code is based on scientific principles. Coupled with this are the facts that
the Code language is rather broad and vague, and others do not have access to

11. INTERNATIONAL OLYMPIC COMMITTEE, ANTI-DOPING RULES APPLICABLE TO THE
GAMES OF THE XXVIII OLYMPIAD IN ATHENS IN 2004, arts. 1–2 (2004), available at
http://www.baseball.com.au/site/baseball/abf/downloads/olympics/IOC%20Anti-Doping%20
Rules%20-%20Athens%202004.pdf?MenuID=National_Teams%2F86%2F0%2CNational_
Senior_Men%2F365%2F6264%2CCURRENT_NEWS%2F1762%2F0&MenuID=National_Tea
ms%2F86%2F0%2CNational_Senior_Men%2F365%2F6264%2CLIBRARY%2F1761%2F0%2C
Athens_Library|News%2F1763%2F0 [hereinafter IOC RULES].
12. WADA CODE, supra note 7, §§ 4.3.1.1–4.3.1.3 (first emphasis added).
13. Id. § 4.3.2.
14. Id. § 4.3.1 (second emphasis added).
15. Id. § 4.3.3 (third emphasis added).
16. “Argument” is defined as “[a] statement that attempts to persuade[.]” BLACK’S LAW
DICTIONARY 114 (8th ed. 2004).
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WADA deliberations on inclusions and deletions to the Prohibited List.17
Clearly, such inability to know the scientific basis of the inclusion criteria
and/or to challenge it on scientific grounds poses the threat of a scientific
monopoly by the IOC, and is a violation of the “spirit of science,” which calls
for peer review of biomedical literature.18 Such IOC control can result in the
banning of innocent athletes from competition, and resultant stories could
decrease the enthusiasm among the young to pursue Olympic sports as a
career.19
III. THE PROHIBITED LIST: NEED FOR GREATER SCIENCE-BASED INCLUSION
CRITERIA
The following selected examples illustrate the need for WADA to
incorporate policies consistent with its stated objectives of preventing drug
abuse and associated health risk to athletes.20
A.

Erythropoietin

Erythropoietin (EPO) is a drug used in clinical medicine to increase the
packed red blood cell volume, which is called a “hematocrit reading.”21
Increasing hematocrit can enhance an athlete’s performance by increased
availability of oxygen.22 The health risks associated with EPO use were first
suspected with the death of several Dutch cyclists who died in their sleep.23
Normal (average) hematocrit values range between forty and fifty percent.24
The risk of stroke increases significantly as hematocrit values increase over
fifty percent and increased hematocrit coupled with hypertension increases
nine-fold the risk of a stroke.25 Dehydration during exercise, as in endurance

17. My efforts in calling WADA to get information about its reasons for dropping caffeine
and the contraceptive agent Yasmin from the Prohibited List were unsuccessful.
18. See Lois Ann Colaianni, Peer Review in Journals Indexed in Index Medicus, 272 JAMA
156, 156 (1994).
19. See J. Savulescu et al., Why We Should Allow Performance Enhancing Drugs in Sport,
38 BRIT. J. SPORTS MED. 666, 669 (2004) (“Linford Christie, who served a two year drug ban
from athletics competition, said that athletics ‘is so corrupt now I wouldn’t want my child doing
it.’”).
20. An exhaustive analysis of such an example is beyond the scope of this effort.
21. Savulescu et al., supra note 19, at 667. A hematocrit reading is “[t]he percentage of the
whole blood volume occupied by the red blood cells after centrifugation.” BLAKISTON’S GOULD
MEDICAL DICTIONARY 597 (4th ed. 1972).
22. See Savulescu et al., supra note 19, at 667.
23. See id.
24. Id.
25. Id.; see also G. Wannamethee et al., Haematocrit, Hypertension, and Risk of Stroke, 235
J. INTERNAL MED. 163, 165 (1994).
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sports, exacerbates this risk by increasing blood viscosity (reducing the ability
to flow) and blood pressure.26
EPO is a banned substance listed under prohibited methods for
enhancement of oxygen transfer.27 However, two other methods to increase
hematocrit are not banned. One method involves the use of a hypoxic air tent,
which costs about $7000.28 The second method, which can increase hematocrit
to dangerous or fatal levels, involves training at high altitudes for extended
periods of time; this method can be even more expensive than the first
method.29 It has been estimated that monthly EPO costs about $120 for 8600
international units; even a four-year use at this dose costs under $6000.30
Therefore, these rules favor the affluent athletes, which does not fit the “spirit
of sport” criteria elaborated by the IOC.
Testing athletes for EPO use ignores another of the IOC’s stated aims for
drug-doping: prevention of health risks. Biological samples tested include
urine or blood. Dr. Don Catlin, director of the only IOC approved laboratory
in the United States, stated that the urine tests, which are more accurate, cost
about $400 per test, while the less accurate blood test costs about $60.31 Urine
tests can detect EPO only when used within forty-eight hours prior to testing.32
These tests provide no information about the risk associated with high
hematocrit values. In addition to direct testing for EPO use, the International
Cycling Union (ICU) has a hematocrit cut-off of fifty percent.33 About five
percent of the population has a natural level greater than fifty percent;34 such
athletes will require additional testing to show that their hematocrit value is
natural. It is also technically difficult to measure EPO because it is an
endogenous substance. Further, the cost of a hematocrit test is about $10.35 In
view of these factors, it is recommended that the IOC abolish chemical testing
for EPO. Instead, it should use the ICU hematocrit cut-off of fifty percent,
with the provision that athletes with a hematocrit greater than fifty percent may
be able to compete if they show evidence that their hematocrit level is natural.
Though this might promote the use of EPO, it will be medically safe. It will
definitely “level the playing field” since every athlete will have the option of

26. Savulescu et al., supra note 19, at 667.
27. PROHIBITED LIST, supra note 6, § M1.
28. Savulescu et al., supra note 19, at 668.
29. Id.
30. Id.
31. EPO Drug Testing Q&A (Sept. 11, 2003), http://letsrun.com/2003/epoqa.php (last
visited Nov. 20, 2005) [hereinafter EPO Q&A].
32. Id.
33. Savulescu et al., supra note 19, at 667.
34. Id.
35. This was the cost of the procedure at the Clinical Reference Laboratory, in Lenexa,
Kansas.
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achieving a safe maximum hematocrit level under supervised conditions. The
cost savings on testing would also be substantial.
The story of Olga Yegerova illustrates that complex drug tests can be in
error, and that such errors in drug testing can unfairly affect an athlete’s career
and reputation.36 Her urine tested positive for EPO in 2001 at the Paris Grand
Prix 5000m event; while the French accepted this as conclusive proof of EPO
use, the International Association of Athletics Federations disagreed, insisting
that a blood test was needed for exclusive proof.37 When Yegerova was tested
for EPO a few weeks later at the World Championships, “her blood test came
back as suspicious, but the urine test did not show EPO usage.”38 As stated,
urine tests do not detect EPO if ingested more than forty-eight hours prior to
testing.39 These events caused one opponent to state that she would not
participate if Yegerova did; two other athletes held up a sign in the stadium
that read, “EPO drug cheats out.”40 “Collateral damage” caused by such
erroneous drug testing may turn promising athletes to other careers.
B.

Steroids

Success stories, such as that of Arnold Schwarzenegger, who used steroids
in the past, would make it difficult to dissuade the public, especially athletes,
from believing in the dangers of steroid use.41 Even with the highly publicized
steroids, “[t]he secrecy that surrounds the use of androgens to enhance
performance makes it difficult to investigate their effects on strength and
performance in an objective and controlled manner.”42 One controlled study
has shown performance enhancement in “normal” men on “supraphysiologic”
doses of testosterone.43 However, a close analysis of the data shows that
exercise and weight training alone can result in significant performance
enhancement; the data also suggests that such improvement might be less

36. See EPO Q&A, supra note 31; Andrew Morton, Yegerova the Top: Athletics Tainted—
by Institutional Racism, http://freespace.virgin.net/bobbing,cardiffcity/yeg.html (last visited Nov.
20, 2005).
37. See EPO Q&A, supra note 31.
38. Id.
39. See supra text accompanying note 32.
40. Morton, supra note 36.
41. See Anne E. Kornblut, The Steroids Hearings: The Politicians: Two Parties in Congress
Are at Odds Only Against Witnesses, N.Y. TIMES, Mar. 18, 2005, at D6.
42. Carrie J. Bagatell & William J. Bremner, Androgens in Men–Uses and Abuses, 334 NEW
ENG. J. MED., 707, 712 (1996).
43. See Shalender Bhasin et al., The Effects of Supraphysiologic Doses of Testosterone on
Muscle Size and Strength in Normal Men, 335 NEW ENG. J. MED. 1 (1996) (finding that high
doses of testosterone along with weight training increased performance due to increased fat-free
muscle mass and size).
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pronounced in individuals with naturally higher abilities.44 Confirmative
clinical studies in athletes to test this hypothesis may be difficult, if not
impossible, due to ethical or risk considerations. Similarly, dose-response
studies, which might also inform us about those dose levels that are beneficial
and those that pose a health risk, would also be difficult to conduct. Therefore,
as a first step, the IOC should encourage and support the development of
animal models to study the effects of steroids on performance and health.
C. Caffeine
The rationale behind the decision to drop caffeine from the Prohibited List
in 2004 is unknown; questions from this Author to WADA officials (phone
calls) were unanswered. It has been speculated, perhaps in jest, that this
decision might have been due, at least in part, to pressure from the soft drink
industry.45 However, the following discussion comparing two stimulants,
namely amphetamine and caffeine, illustrates the complex pharmacological
issues that need to be considered when making decisions of either inclusion or
exclusion of a stimulant to the Prohibited List.46
The use of many (about forty) stimulants, identified by name, are banned
with the added proviso that “other substances with a similar chemical structure
or similar biological effect(s)” are also included.47 Such a proviso can be a
pharmacological nightmare for any athlete or coaching staff. Caffeine, a
stimulant, was removed from the Prohibited List in 2004; amphetamine
continues to be on the List.48 The pharmacology of both is similar, though
amphetamine is a more potent stimulant than caffeine.49
Improved
performance with amphetamine was observed in “highly” trained athletes such

44. See id. at 5 (placing results in a table). The participants in this study were “normal”
men, ages 19 to 40 years, and had experience with weightlifting. Id. at 2. In a ten-week span,
men who began only able to lift 126 kilograms squatting increased performance to 151 kilograms
through weight training alone (a 20% increase). Id. at 5. The testosterone group (those ingesting
600 mg of testosterone for the ten weeks) increased squatting from a baseline (average) of 102 kg
to 140 kg (a 37% increase). Id.
45. Comments made at the 17th Annual Health Law Symposium: Sports Medicine: Doping,
Disability and Health Quality, Saint Louis University School of Law, March 18, 2005.
46. This discussion is by no means a complete discussion of the pharmacology of
amphetamine and caffeine; such discussion is beyond the scope of this Review.
47. PROHIBITED LIST, supra note 6, § S6.
48. CANADIAN CENTRE FOR ETHICS IN SPORT, ADVISORY NOTE: THE 2004 WADA
PROHIBITED LIST: SUMMARY OF REVISIONS, http://www.cces.ca/pdfs/CCES-ADV-2004WADA
ProhibitedList-E.pdf; see PROHIBITED LIST, supra note 6, at § S6.
49. See P. N. R. Dekhuijzen et al., Athletes and Doping: Effects of Drugs on the Respiratory
System, 54 THORAX 1041, 1042 (1999), available at http://thorax.bmjjournals.com/cgi/reprint/
54/11/1041?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&andorexactfulltext=and&s
earchid=1126823303800_2949&stored_search=&FIRSTINDEX=0&sortspec=relevance&volume
=54&firstpage=1041&resourcetype=1&journalcode=thoraxjnl.
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as swimmers, runners, and weight throwers; improved performance was
attributed to the masking of the fatigue and/or pain.50 While performance
enhancement results with caffeine were less definitive, it was reported that
while “major effects of caffeine on exercise capacity have not been found, . . .
some small (but, in competitive sports, important) effects may be present.”51
Further, caffeine increases the use of free fatty acids in the blood, which can
serve as an additional fuel source to glycogen and thus promote performance.52
From a pharmacological point of view, it is important for the IOC to justify the
retention of amphetamine, and other less potent stimulants, but not caffeine, on
the Prohibited List.
In general, tests based on urine concentrations of drugs, though convenient,
are fraught with problems that are widely recognized in pharmacological
circles; for example, water consumption or urine acidity can influence such
concentrations.53 When caffeine was banned, its use was established if the
urine concentration was twelve micrograms per milliliter or greater.54
Therefore, even when caffeine was a prohibited substance, athletes and
coaches knowledgeable of the principles of urinary drug excretion could have
developed pharmacokinetic strategies to escape detection.55 Obviously, it
would be almost impossible to document such cases. The case of Ms. Terri
Edwards, a sprinter for the United States Olympic Team, illustrates the reverse
situation, where the coaching staff appeared to be unfamiliar with drugs and
supplements; this lack of expertise had a major negative impact on her career.56
A urine sample obtained from Edwards on April 24, 2004, tested positive for
nikethamide, a prohibited stimulant; she had ingested two “Coramine Glucose”
tablets, given to her by her physical therapist (chiropractor).57 On June 21,
2004, the United States Anti-Doping Agency (USADA) charged her with

50. See id.; Joe V. Chandler & Steven N. Blair, The Effect of Amphetamines on Selected
Physiological Components Related to Athletic Success, 12 MED. & SCI. SPORTS & EXERCISE 65,
66, 68 (1980).
51. Dekhuijzen et al., supra note 49, at 1043.
52. Endurance Research Board, Caffeine and Endurance, TRIFUEL (Feb. 2, 2004),
http://www.trifuel.com/triathlon/nutrition/caffeine-and-endurance-000402.php (last visited Nov.
20, 2005).
53. See MILO GIBALDI & DONALD PERRIER, PHARMACOKINETICS 253–54 (1975), reprinted
in 1 DRUGS AND THE PHARMACEUTICAL SCIENCES (James Swarbrick ed., Marcel Dekker, Inc.
1975).
54. Endurance Research Board, supra note 52.
55. “Pharmacokinetics” is the study of the rates of absorption, distribution, metabolism, and
excretion of drugs and the effects of these rates on their actions. GIBALDI & PERRIER, supra note
53, at v.
56. See Edwards v. Int’l Ass’n of Athletics Fed’ns, CAS Arb. OG 04/003 (Ct. of Arb. for
Sport 2004).
57. Id. at 14–16.
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doping and recommended a 2-year suspension.58 The product label clearly
indicated that it contained 125 milligrams of nikethamide.59 On appeal, the
Court of Arbitration for Sport (CAS) upheld the suspension, though it noted
that “the Panel is satisfied that she has conducted herself with honesty,
integrity and character and that she has not sought to gain any improper
advantage or to ‘cheat’ in any way.”60
Another issue that further questions the pharmacological rationale of
dropping caffeine from the Prohibited List is that, in rat studies, caffeine
potentiates the effects of cathinone, a prohibited substance.61 While these
effects do not appear to be performance-related, it further questions the
deletion of caffeine from the Prohibited List.
D. Marijuana
Cannabinoids are prohibited,62 though nobody really believes that
marijuana is a performance-enhancing drug. In fact, marijuana most probably
impairs performance.63 One widely reported controversial case related to
marijuana use in competitive sports illustrates the ineffectiveness and
confusion regarding implementation of IOC rules to prevent drug use in
sports.64 Ross Rebagliati, a Canadian, won the gold medal for snow boarding
at the 1998 Winter Olympics in Nagano, Japan.65 A urine sample obtained
from Rebagliati “immediately after he won” had a concentration of 17.8
nanograms per milliliter (ng/ml) of cannabis metabolites.66 Based on this
finding, the IOC stripped him of his medal.67 On appeal, the CAS reversed the
IOC decision stating the IOC “had disqualified Rebagliati even though the IOC
has no prohibitions or sanctions for the use of cannabis (marijuana).”68 While
the IOC had no doping rules relating to marijuana, the International Ski

58.
59.
60.
61.

Id. at 2.
Id. at 16.
Id. at 15, 16.
Martin D. Schechter, Potentiation of Cathinone by Caffeine and Nikethamide, 33
PHARMACOL. BIOCHEM. & BEHAV. 299, 300 (1989); see PROHIBITED LIST, supra note 6, § S6.
62. PROHIBITED LIST, supra note 6, § S8.
63. See Kari Egan & Brandon Arnold, History of Snowboarding in the Olympics, ABOUT,
http://snowboarding.about.com/od/snowboardingbackground/a/Olympic_history.htm (last visited
Nov. 20, 2005).
64. See id.
65. Id.
66. Sports Court Overturns IOC Marijuana Ruling, SHINANO MAINICHI (Japan), Feb. 11,
1998, http://www.shinmai.co.jp/oly-eng/19980212/0009.htm (last visited September 9, 2005)
[hereinafter Sports Court].
67. Egan & Arnold, supra note 63.
68. Sports Court, supra note 66.
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Federation (FIS),69 the governing body for skiing and snowboarding, sets a
limit of 15 ng/ml for cannabis metabolites.70 Since there was no official
agreement between the IOC and the FIS regarding marijuana, the IOC did not
have the authority to enforce the latter’s prohibitions.71 Since only athletes
who possess the financial resources to bring such appeals can contest such
decisions, as with the EPO regulations, less affluent athletes are at a
disadvantage.
Later events related to this story also demonstrate that, by using selective
facts advantageous to their cause, those who benefit from and advocate drug
testing exaggerate the significance of their efforts. More than a year later, in
1999, Barry McCaffrey, director of the Office of National Drug Control Policy
(ONDCP), testified before Congress:
Today, the Office of National Drug Control Policy is releasing a national
strategy to help address the threat of drug use and doping in sport . . . . This
Strategy builds upon a series of important successes. ONDCP pushed the
International Olympic Committee (IOC) to make marijuana a banned
substance after an athlete who tested positive for marijuana was awarded the
Olympic gold and hoisted up on the medal platform as a hero to all the world’s
youth. The IOC responded and marijuana is now prohibited.72

The failure of McCaffrey to include the reversal by the CAS in his testimony
ignores the ineffectiveness of the IOC in enforcing its anti-doping rules.
Apparently, he considers this a major victory against drug doping because he
refers to this incident a second time in his testimony, where he states, “[s]ince
the infamous Nagano snowboarding incident described above.”73 Clearly,
marijuana use is not one of the serious problems in drug doping. In fact,
Rebagliati had argued in his defense that his exposure this time was due to
“second hand” smoke;74 while not so indicated, it is likely to have been another
reason for the CAS to reinstate his gold medal.

69. The International Ski Federation is commonly known as the FIS, which stands for
FJdJration Internationale de Ski.
70. Rebagliati Wins Back His Gold, MOUNTAIN ZONE, Feb. 12, 1998,
http://classic.mountainzone.com/olympics/nagano/up2-12a.html (last visited September 9, 2005).
71. Id.
72. Effects of Performance Enhancing Drugs on the Health of Athletes and Athletic
Competition: Hearing Before the S. Comm. on Commerce, Sci., & Transp., 106th Cong. 13
(1999), available at http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_senate_
hearings&docid=f:75594.pdf (statement of General Barry R. McCaffrey, Director, Office of
National Drug Control Policy).
73. Id. at 19.
74. Rebagliati Wins Back His Gold, supra note 70.
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Growth Hormone

Human growth hormone (hGH) is another prohibited substance.75
However, there is little evidence that this hormone is a performanceenhancement substance.76 “In any case most elite athletes have low body fat,
so it is doubtful whether any small increase in power to weight ratio as the
result of loss of more fat could be significant in terms of increased
performance.”77 The belief that hGH has an anabolic effect is based on results
in hGH-deficient adults.78 In fact, hGH can decrease performance in healthy
adults; in studies conducted at the Danish Institute of Sports Medicine, athletes
were unable to complete cycling tasks after being treated with hGH.79
Ironically, use of this hormone in sports has been inadvertently promoted by
anti-doping authorities by merely listing it as a prohibited substance.
Educational efforts to inform athletes that hGH “does not ‘work’” in normal
healthy subjects and that its use has “immediate and long term hazards—
everything from decreased performance to cancer” is likely to be more
effective in combating its use among athletes.80
F.

Diuretics and Other Masking Agents

The use of diuretics and other masking agents is prohibited.81 Diuretics are
agents that increase urine output.82 The major “masking” effect is the decrease
in concentrations of other prohibited substances due to this increased urine
volume, making the detection of other prohibited substances in the urine
difficult. It is beyond the scope of this Review to discuss the wide availability
of sensitive and specific methods for detecting many prohibited substances in
the urine.83 These methods are capable of detecting parts per billion
(nanogram quantities) or parts per trillion (picogram quantities). The IOC
should expand the use of these methods to anti-doping efforts, which should
simplify the Prohibited List by removing many currently prohibited diuretics
from the list. Such simplification would be very helpful to an honest athlete,
for whom the fear of accidental ingestion of a prohibited substance is real.

75. PROHIBITED LIST, supra note 6, § S2.
76. M. J. Rennie, Claims for the Anabolic Effects of Growth Hormone: A Case for the
Emperor’s New Clothes, 37 BRIT. J. SPORTS MED. 100, 103 (2003); see Dekhuijzen et al., supra
note 49, at 1044, 1046 nn. 82–84.
77. Rennie, supra note 76, at 103.
78. Id. at 102.
79. Id. at 103 (discussing study of Dr. Kai Lange of the Danish Institute of Sports Medicine).
80. Id.
81. PROHIBITED LIST, supra note 6, § S5. The list names about twenty compounds. Id.
82. BLAKISTON’S GOULD MEDICAL DICTIONARY 402 (4th ed. 1935).
83. See generally M. Thevis & W. Schanzer, Mass Spectrometry in Doping Control
Analysis, 9 CURRENT ORGANIC CHEM. 825, 825–44 (2005).
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The inclusion in 2003 of the oral contraceptive Yasmin to the Prohibited
List, and its subsequent quick removal in 2005, clearly shows the need for the
IOC to exercise scientific restraint in preparing this List. The Athlete Advisory
in 2003 stated: “Yasmin, a popular birth control pill, contains a prohibited
substance—the diuretic DROSPIRENONE. The purpose of the diuretic is to
prevent the retention of water. The use of Yasmin could, therefore, result in an
adverse laboratory finding and a doping violation.”84 In 2005, the IOC
removed Yasmin from the prohibited list without comment.85 Attempts by this
Author to get additional information from WADA (phone calls) about these
deletions from the Prohibited List were unsuccessful. By its own admission,
WADA recognized the wide use of this contraceptive, and therefore, certainly
should have recognized the unnecessary disruption to the daily lives of female
athletes brought about by prohibiting its use.
IV. SUGGESTIONS FOR IMPROVING THE CHEMICAL DRUG TESTING PARADIGM
The major intent of these recommendations is to ask WADA to simplify
the Prohibited List and provide explanatory notes for the inclusion of each
substance or method in the List. Such an “athlete-friendly” list is likely to
improve compliance and minimize inadvertent violations which have
devastating effects on the careers and lives of athletes. In this context, antidoping agencies should revisit the issue of strict liability.
This standard makes enforcement easier. However, there are other issues
that must also be considered. First, many athletes use dietary supplements that
are not prohibited to enhance performance, though the claimed beneficial
effects of many of these products remain clinically unproven. Second, many in
the sports world appear to be unaware that many of these products are
contaminated because they are not manufactured under the high standards used
for drugs and do not require pre-market approval by the Food and Drug
Administration (FDA).86 In 2003, the FDA proposed a rule that would require
84. United States Anti-Doping Agency, Athlete Advisory—Update on Prohibited Substance
List/Yasmin (July 2, 2003), http://www.usantidoping.org/files/active/athletes/athlete%20
advisory-yasmin[1].pdf (emphasis added).
85. United States Anti-Doping Agency, Athlete Advisory—YASMIN (Jan. 27, 2005),
http://www.usantidoping.org/files/active/atheletes/athelete%20advisory%20-%20yasmin[3]pdf.
The Advisory merely stated: “On January 25, 2005, the World Anti-Doping Agency (WADA)
List Committee considered the status of Yasmin, an oral contraceptive. Today, WADA notified
USADA that the medication, Yasmin, is allowed in- or out-of-competition, effective
immediately.” Id.
86. See Current Good Manufacturing Practice in Manufacturing, Packing, or Holding
Dietary Ingredients and Dietary Supplements, 68 Fed. Reg. 12,158 (Mar. 13, 2003) (to be
codified at 21 C.F.R. pts. 111, 112) (presenting several examples of contaminated dietary
supplements). Under the Dietary Supplement Health Education Enhancement Act (DSHEA), premarket approval is not required for dietary ingredients intended for use in dietary supplements.
Id. at 12,915.
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that these supplements be manufactured under standards of current good
Third,
manufacturing practices; a final rule is expected in 2005.87
sophisticated chemical analytical methods can detect minute88 amounts of
prohibited substances; more sensitive and specific methods are expected in the
future. Therefore, the detection limits are well below pharmacological
thresholds for performance enhancement, the main reason athletes ingest these
supplements. Besides, there is an acute lack of data to support the conclusion
that many of the substances or methods listed in the current Prohibited List do
enhance performance. The standard of strict liability as applied to drug testing,
though highly pragmatic, is based on a ritualistic “gotcha” policy, which
neither enhances the stature of competitive Olympic sports, nor the IOC. In
contrast, the stated standard of proof for doping is the “balance of probability”
standard; this standard is greater than “a mere balance of probability but less
than proof beyond a reasonable doubt.”89 It is recommended that, when an
athlete tests positive for a prohibited substance, anti-doping agencies allow, on
a case by case basis, expert pharmacological testimony to the issue of
performance enhancement. While such a change would clearly make the
current proceedings more confrontational and prolonged, it will be fairer to
athletes. In one example, an athlete inhaled a prohibited substance when he
used the American brand of Vicks, a decongestant inhaler, instead of the
British brand.90 However, even some athletes are in support of the strict
liability standard.91 It would appear that the examples stated above provide the
“blinding reason and cause” needed to reconsider this standard of liability.92
It appears that the mission of anti-doping agencies today is to make sports
“squeaky clean” of drugs, whether they enhance an athlete’s performance
abilities or not. They have become de facto drug enforcement agencies for
athletes. Hence, the Prohibited List includes everything “under the sun” that is
perceived to offer an advantage. The unanticipated negative consequence of
such a draconian approach is that it promotes drug doping. The mere listing of
a substance or method in such a list is misinterpreted by most athletes that the
substance or method offers an advantage. The logic simply is: If a substance
or method does not offer an advantage, why would WADA put it on the list?

87. See id. at 12,158.
88. Parts per billion (nanograms) or parts per trillion (picograms).
89. IOC RULES, supra note 11, § 3.1.
90. Savulescu et al., supra note 19, at 669.
91. Id. (“The rule of strict liability—under which athletes have to be solely and legally
responsible for what they consume—must remain supreme. We cannot, without blinding reason
and cause, move one millimetre from strict liability—if we do, the battle to save sport is lost.”)
(quoting Sebastian Coe, We Cannot Move from Strict Liability Rule, DAILY TELEGRAPH (UK),
Feb. 25, 2004, Sports, at 5, available at http://www.telegraph.co.uk/sport/main.jhtml?xml=/sport/
2004/02/25/socoe25.xml).
92. Id.
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So, it is recommended that WADA convene a panel consisting primarily of
clinical and basic pharmacologists, exercise physiologists and sports medicine
researchers, and bioanalytical chemists to reconsider the following central and
related questions:
(1) Does competent science support the belief that a listed substance enhances
performance? This is the key question because athletes “take drugs” to
enhance performance. Further, making public the rationale for inclusion of
a substance or method, along with supporting data such as specific
publications or bibliography used to make inclusion or deletion decisions,
will enable anti-doping agencies to educate athletes and to receive
constructive comments from the scientific community at large.
(2) How can chemical analytical tools available today be better used to detect
drugs of abuse in biological fluids such as urine, blood, and other body
fluids and tissues? Such knowledge, for example, could eliminate or
drastically minimize the number of prohibited substances, such as
diuretics.
(3) What are the “information” gaps in knowledge regarding drug use and
performance? This would help in designing appropriate clinical studies;
when such studies are not possible for ethical or health risk reasons, there
should be development of animal models to study drug-induced
performance enhancement.

As new understanding of the physiology of athletic performance becomes
available, efforts by anti-doping agencies to curb doping and cheating by
athletes (the “cat and mouse game”) could become irrelevant. For example, it
was recently reported that lactic acid, whose accumulation is believed to cause
muscle fatigue, may have beneficial effects on muscle performance.93 Athletes
now use many approaches, such as creatine supplementation, carbohydrate
loading, and high-altitude training to combat muscle fatigue.94 Athletes and
trainers, especially in developed countries, who have the resources to
understand and apply such information are likely to benefit from such new
developments.
93. David Allen & Hakan Westerblad, Lactic Acid—The Latest Performance-Enhancing
Drug, 305 SCIENCE 1112, 1112–13 (2004). Using isolated frog muscle preparations, it was
shown in 1929 that lactic acid accumulation, caused by electrical stimulation, decreased
mechanical performance. Id. at 1112. When the accumulated lactic acid was removed by
immersing the muscle preparation in a suitable saline solution, muscle performance improved.
Id. For more details, see generally Thomas H. Pedersen et al., Intracellular Acidosis Enhances
the Excitability of Working Muscle, 305 SCIENCE 1144 (2004).
94. Cathy M. Fomous et al., Symposium: Conference on the Science and Policy of
Performance-Enhancing Products, 34 MED. & SCI. SPORTS & EXERCISE 1685, 1685–86 (2002).
Creatine, though not a prohibited substance, has been reported to improve performance by five to
ten percent “during short duration, high intensity types of exercise.” Id. at 1688. However, not
all studies have been able to show this improvement. Id.
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Drug abuse in sports in America has become an over-sensitized, emotional
issue; the recent Senate hearing on steroid use in baseball is one such
example.95 On the other hand, there is hardly any discussion on the use of
drugs by musicians to suppress stage fright, and thus improve performance.96
Historically, efforts to curb recreational drug use have not fared well.
Prohibition was repealed; the success of drug enforcement agencies in
combating drug abuse in the general public has been limited at best. It is
therefore reasonable to believe that efforts to combat drug use in sports
through drug testing are unlikely to be a big success. It has been argued that
drugs should be made legal, because “[b]y allowing everyone to take
performance enhancing drugs, we level the playing field.”97 The relatively
small number of athletes who are “caught” suggest that either drug abuse is not
a rampant problem or, if it is rampant, that most of the “cheaters” escape
detection. In conclusion, the IOC, by exposing myths of drug-induced
performance enhancement, and educating athletes regarding the risks and lack
of effectiveness of many popular drugs and dietary supplements, combined
with limited drug testing, is likely to be more successful in combating the
problem of drug doping in sports.

95. See Restoring Faith in America’s Pastime, supra note 3.
96. See Savulescu et al., supra note 19, at 667 (noting that Beta blockers, which lower blood
pressure and heart rates, have been used by classical musicians to enhance performance by
combating physical effects of stress).
97. Id. at 668.
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